baber/WOPTO huggingface dataset:
Patent DE-69731949-T2 (DE)
Inventor: THIBERG ROLF
IPC: A61N5/06
Filed: 1997-06-04
Granted: 2005-10-06
Abstract: Apparatus for external medical treatment with the aid of light. A light-emitting device is provided that includes light-emitting diodes or corresponding elements and is adapted to emit monochromatic light of a predetermined wavelength. The light emitting device is driven by a drive arrangement for causing the light-emitting device to emit the monochromatic light over a predetermined time and is intended to lie against or to be held in close proximity to acupuncture points on the body of an individual. The drive arrangement also is adapted to cause the light-emitting device to pulsate the light in accordance with a predetermined pulse frequency, and to cause the light-emitting device to emit the pulsating monochromatic light at a pulse repetition frequency in one of the ranges 5 Hz to 9.5 Hz, 22.2 Hz to 36.0 Hz, and 273.8 Hz to 324.0 Hz.
Patent DE-69733021-T2 (DE)
Inventor: CARRERA PIETRO
IPC: C05F17/02
Filed: 1997-10-03
Granted: 2006-02-16
Abstract: A plant for the biological treatment of solid organic waste, where the organic mass is fed into a treatment tank with a horizontal bottom, while screw propellers, suspended from a sliding bridge parallel to tank base, operate immersed in the matter and whose axis is inclined according to a convenient angle, preferably between 5° and 50°, compared to its vertical, moving the organic matter from the bottom upwards and from the inflowing side of the treatment tank to the outflowing one, continuously immersed in a direction which is at right angles compared to the direction of movement of the organic mass and remaining continuously active, that is without any idle return of the screw propellers across the treatment tank after each process cycle.
Patent DE-69737723-T2 (DE)
Inventor: MURDOCK THOMAS O
IPC: A61N1/30
Filed: 1997-12-09
Granted: 2008-01-31
Abstract: A novel electrotransport drug delivery system (10) and therapeutic agent-containing reservoir (26, 28) for use therein are provided. An inert filler material effective to reduce the quantity of therapeutic agent otherwise present is incorporated in the reservoir (26, 28) along with the therapeutic agent to be delivered via electrotransport. Methods for making the reservoir (26, 28) and drug delivery system (10) are provided as well.
Patent DE-69737756-T2 (DE)
Inventor: ZDEBLICK THOMAS A
IPC: A61F2/30
Filed: 1997-02-19
Granted: 2008-01-31
Abstract: An interbody fusion device (10') in one embodiment includes a load bearing body (11') defining a hollow interior or chamber (15) for receiving an osteogenic material. In another embodiment, the tapered body is solid and formed of a porous biocompatible material having sufficient structural integrity to maintain the intradiscal space and normal curvature. The material is preferably a porous tantalum composite having a fully interconnected pores to facilitate complete bone tissue ingrowth into the implant. A cap (300) is also provided to block the opening (15a) of the hollow fusion device (10'). The cap (300) includes an occlusion body (301) and an elongated anchor (310). In some embodiments the anchor includes a lip (315) which is engageable to openings (24') in the body wall. Tools are also provided for manipulating caps for interbody fusion devices. In one embodiment the tool includes a cap-engaging tip for engaging a threaded tool hole (320) in the cap (300). <IMAGE>
Patent DE-69803419-T2 (DE)
Inventor: CHABAL CLAUDE
IPC: D04H13/00
Filed: 1998-03-09
Granted: 2002-08-01
Abstract: The invention concerns a multilayer textile material useful in particular for armouring reinforcement of membrane roofing system, consisting of a complex comprising a textile grid embedded inside a textile structure consisting on non-woven laps arranged on either side of the grid, said laps being mutually linked by the entanglement of the lap fibres, resulting from the action of fluid (air water) jets, which drive the fibres through the grid and distribute them on either side thereof without damaging it, the two laps being made up of synthetic fibres. The invention is characterised in that: the grid is made with base of glass or polyester fibre; the textile laps arranged on either side of the grid are based on polyester fibres, at least one of these laps comprising 20 to 40 % of fibres selected from the family of fibres with high resistance to fire and heat.
Patent DE-69804351-T2 (DE)
Inventor: SATTERFIELD D
IPC: H04N21/431
Filed: 1998-11-12
Granted: 2002-07-18
Abstract: An inter pap active television program guide system is provided in which a user may direct the program guide to display a browsing display screen. The browsing display screen includes a list of current programs including a movable highlight region, a video window containing a television program to which the system is currently tuned, and a detailed description of the highlighted program listing. The user may position the highlight region using remote control cursor keys. The user may then synchronize the content of the video window with the highlighted program listing by pressing a select key or a channel up or down key. If the user changes channels repeatedly using the channel up and down keys, the contents of the video window and the highlighted program listings remain in synchronization.
Patent DE-69813553-T2 (DE)
Inventor: HENRICHS MARK
IPC: A61K49/00
Filed: 1998-05-19
Granted: 2004-03-04
Abstract: The invention relates inter alia to a method of generating information from an animate human or non-human animal body which method comprises: administering to said body a physiologically tolerable material capable of absorbing, scattering or emitting light at a wavelength in the range 300 to 1300 nm; subjecting at least a portion of said body to ultrasound irradiation; detecting light in the wavelength range 300 to 1300 nm from said portion of said body; and manipulating the detected light to generate said information.
Patent DE-69824971-T2 (DE)
Inventor: OHASHI MAMORU
IPC: A61K31/499
Filed: 1998-10-15
Granted: 2004-12-23
Abstract: A stabilized pharmaceutical composition comprising (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo-Ä1,2-aÜpyrazi ne-4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (hereinafter, referred to as "AS-3201") and as a stabilizer at least one acidic substance having an acidity more potent than that of AS-3201, such as ascorbic acid, citric acid, tartaric acid, lactic acid, maleic acid, malic acid or phosphoric acid.
Patent DE-69832156-T2 (DE)
Inventor: WORLEY F
IPC: C12N15/12
Filed: 1998-03-13
Granted: 2006-08-03
Abstract: Disclosed are nucleotide coding sequences and polypeptide sequences for synaptic activation binding proteins that are characterized by induction in the central nervous system following neuronal activity in rat hippocampus. Such proteins are identified by (i) substantial homology at the nucleotide or protein sequence level to specifically defined rat, human or mouse coding sequences or proteins, (ii) ability to bind to and affect the activity of effector proteins in the CNS, such as metabotropic glutamate receptors, (iii) binding specificity for a particular binding sequence, and (iv) presence in the sequence of a PDZ-like domain. Nucleotides and polypeptides of the invention are useful in screening and diagnostic assays.
Patent DE-69833059-T2 (DE)
Inventor: SCHMIDT RICHARD A
IPC: A61P13/02
Filed: 1998-07-15
Granted: 2006-08-03
Abstract: The present application is directed to the use of a therapeutically effective amount botulinum toxin in the preparation of a pharmaceutical composition for treating a patient with a neurogenic bladder dysfunction, wherein the composition is to be administered by injection into a bladder wall of a patient with said neurogenic bladder dysfunction, thereby treating a symptom of said neurogenic bladder dysfunction.
Patent DE-69835696-T2 (DE)
Inventor: KATO YASUYOSHI
IPC: B01J23/28
Filed: 1998-11-12
Granted: 2007-08-16
Abstract: The catalyst structure of the present invention for purifying an exhaust gas is preferable for increasing the contact of an exhaust gas, to be treated, with a catalyst by disturbing the flow of the exhaust gas in a gas flow passage thereby obtain a highly efficient and compact apparatus for treating the exhaust gas. Such catalyst structure is produced by forming two or more catalyst elements each supporting a catalyst component on its surface and having flat plate portions and level-changing portions formed alternately therein with the angle formed between the flat plate portion and the level-changing portion being in a specific range, and then stacking the catalyst elements in a frame. A catalyst structure is also obtained by stacking a large number of the catalyst elements described above through metallic, ceramic, or glass netlike members interposed therebetween and each having a large number of perforated holes. The catalyst structure has such advantages that dust is hardly deposited between the catalyst elements, that a sufficiently high strength can be obtained even when the thickness of catalyst elements is reduced, and that the catalyst structure can be placed in an exhaust gas flue to use as an exhaust gas treating apparatus. When the exhaust gas treating apparatus is employed, an efficient exhaust gas treatment can be effected without damaging the catalyst elements while repressing the pressure loss. <IMAGE>   <IMAGE>
Patent DE-69837751-T2 (DE)
Inventor: KOMEDA TOSHIHIRO
IPC: C12N15/00
Filed: 1998-08-28
Granted: 2008-01-31
Abstract: The present invention relates to a DNA comprising the nucleotide sequence shown in SEQ ID NQ:1, or a DNA for enhancing promoter activity which comprises a nucleotide sequence having deletions, substitutions, additions or insertions of one or more nucleotides in the nucleotide sequence shown in SEQ ID NO;1; to a mutant promoter comprising one or more fragments of the DNA; to a recombinant expression vector comprising the mutant promoter together with a heterologous gene; to a transformant prepared by transforming a host cell with the vector; to a process for preparing an expression product, comprising culturing the transformant in a medium, and recovering the expression product of a heterologous gene from the obtained culture; and to a method for enhancing a promoter activity, characterized in that one or more fragments of the above-defined DNA are located at at least one position preceding, following or within a selective promoter in a forward or reverse direction.
Patent DE-69905579-T2 (DE)
Inventor: REESINK HENDRIK
IPC: C10G45/06
Filed: 1999-07-20
Granted: 2003-09-25
Abstract: The invention is directed to a process for the hydrogenation of a sulfur containing feedstock, having a sulfur content of less than 50 ppm, wherein the feedstock is hydrogenated in the presence of a precious metal catalyst and a nickel-catalyst, said process being carried out in such a manner, that   the feedstock is contacted with a mixture of precious metal catalyst, metal oxide and nickel catalyst, the feedstock is contacted initially with the precious metal catalyst followed by contact with the metal oxide and nickel catalyst, either in combination or sequentially, or the feedstock is contacted first with a mixture of precious metal catalyst and metal oxide, followed by contact with the nickel catalyst.
Patent DE-69910101-T2 (DE)
Inventor: SEBASTIAN ALICE
IPC: C07D307/77
Filed: 1999-02-24
Granted: 2004-05-13
Abstract: A novel process for the preparation of codeinone and analogues thereof comprising the oxidation of a compound of formula, <CHEM>     or a salt thereof, wherein R<1> is lower alkyl or a group <CHEM> wherein R<4> is lower alkyl, lower alkyl substituted by halogen or phenyl, phenyl or substituted phenyl; and R<2> is lower alkyl, allyl or lower alkyl substituted by cycloalkyl, characterised in that the oxidation is carried out in an acidic environment is disclosed.
Patent DE-69910975-T2 (DE)
Inventor: LEDUC MADELEINE
IPC: A61K8/22
Filed: 1999-01-18
Granted: 2004-07-22
Abstract: The invention relates to the use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres, to cosmetic compositions using them and to method for treating hair with the aid of these polymers.
Patent DE-69911155-T2 (DE)
Inventor: GOTO HIROSHI
IPC: B41C1/00
Filed: 1999-12-17
Granted: 2004-06-09
Abstract: A roll-shaped thermosensitive recording material having a thermosensitive recording layer, which includes as main components an electron donating coloring agent, an electron accepting color developer and a binder resin and which is formed overlying a substrate, wherein the roll-shaped thermosensitive recording material has a variation (R) of thickness of in the lateral direction of not greater than 3  mu m. Preferably the roll-shaped thermosensitive recording material has a difference in thickness between the left side and the right side in the lateral direction of not greater than 0.7  mu m.
Patent DE-69912839-T2 (DE)
Inventor: HE KAN
IPC: C07D513/04
Filed: 1999-12-21
Granted: 2004-11-11
Abstract: Provided are products including trihydroxystilbenes and glycosylated derivatives thereof. Also provided are compositions containing these products with an aqueous solvent, particularly and alcohol-water mixture, and reverse phase chromatographic methods for isolating and purifying the compositions from plant materials. The products have biological activity, including anti-tumor activity.
Patent DE-69915479-T2 (DE)
Inventor: HARRIS GREGORY
IPC: B42D25/328
Filed: 1999-06-09
Granted: 2004-08-19
Abstract: A method of providing an optically variable effect generating structure on a substrate. The method comprises a) providing an adhesive on the substrate; b) depositing a metal powder on the adhesive; and, c) embossing an optically variable effect generating structure into the metal powder. A method of providing an image on a substrate, the method comprising a) providing an adhesive on the substrate in a pattern corresponding to an image; and, b) depositing a metal powder on the adhesive.
Patent DE-69925988-T2 (DE)
Inventor: SHIBATA MARI
IPC: D04B1/00
Filed: 1999-01-08
Granted: 2006-05-04
Abstract: A process for treatment of warp knitted fabrics containing regenerated cellulose fibers comprises crumpling the fabrics and subjecting the resultant fabrics to alkaline treatment in a spread state. An independent claim is also included for a warp knitted fabric containing regenerated cellulose fibers with an X-ray crystallinity of 46-60% and X-ray crystallization completeness of 0.15-0.3.
Patent DE-69928778-T2 (DE)
Inventor: PORTA ROBERTO
IPC: A61K47/48
Filed: 1999-06-08
Granted: 2006-07-06
Abstract: The invention relates to the use as medicaments, specifically as antiinflammatories, of complexes formed by cationic liposomes and polydeoxyribonucleotides having a molecular weight in the range 7,000-60,000 Da obtainable by depolymerization of nucleic acids, wherein in said complexes the polydeoxyribonucletoides are located on the outer surface of the liposome.
Patent DE-69930473-T2 (DE)
Inventor: KARTCHNER HENRY H
IPC: C10G33/06
Filed: 1999-05-07
Granted: 2006-12-14
Abstract: A microwave applicator to effectively break hydrocarbon and water emulsions with radio frequency energy. A stream of hydrocarbon and water emulsion is pumped into a multimode resonant reentrant microwave cavity. Dual opposing emulsion flow chambers with a centrally supplied microwave waveguide form a double ended resonant chamber with multiple RF energy reflections to effectively treat the flowing emulsion. The emulsified feedstock enters into the bottoms of both flow chambers and exits to a centrifuge or storage for separation. <IMAGE>
Patent DE-69931048-T2 (DE)
Inventor: RAK STANISLAW
IPC: B01D53/86
Filed: 1999-03-30
Granted: 2006-09-21
Abstract: The invention relates to a method for the catalytic reduction of dinitrogen oxide (N2O) in the presence of zeolite with the addition of a reducing agent, characterised in that the reducing agent used is a saturated hydrocarbon such as methane (CH4), propane (C3H8), LPG (C3H8/C4H10) or a combination of these reducing agents. It has been found that temperatures of 400  DEG C or lower can be achieved for complete N2O conversion even with very low concentrations of the reducing agent and in the presence of water vapour.
Patent DE-69938508-T2 (DE)
Inventor: BERTRAND BENOIT PATRICK
IPC: G09B7/04
Filed: 1999-02-08
Granted: 2009-05-07
Abstract: A system is disclosed that provides a goal based learning system utilizing a rule based expert training system to provide a cognitive educational experience. The system provides the user with a simulated environment that presents a business opportunity to understand and solve optimally. Mistakes are noted and remedial educational material presented dynamically to build the necessary skills that a user requires for success in the business endeavor. The system utilizes an artificial intelligence engine driving individualized and dynamic feedback with synchronized video and graphics used to simulate real-world environment and interactions. Multiple "correct" answers are integrated into the learning system to allow individualized learning experiences in which navigation through the system is at a pace controlled by the learner. A robust business model provides support for realistic activities and allows a user to experience real world consequences for their actions and decisions and a tutorial system analyzes student inputs to determine appropriate feedback to teach new skills.
Patent MD-3468957-T2 (MD)
Inventor: FU JIPING
IPC: C07D261/08
Filed: 2017-06-12
Abstract: Această invenţie se referă la un compus cristalin cu Formula (A) aşa cum este descris în aceasta şi la compoziţii conţinând acest compus cristalin, precum şi la metode de utilizare a compusului sau compoziţiilor farmaceutice care îl cuprind pentru a trata infecţii bacteriene. Compusul şi compoziţiile sunt în mod special folositori pentru a trata infecţii bacteriene Gram-negative, inclusiv tulpini rezistente la multiple medicamente.
Patent MD-3500593-T2 (MD)
Inventor: ALTEN LEONIE
IPC: C07K14/78
Filed: 2017-07-04
Abstract: Prezenta invenţie se referă la construcţii de recunoaştere antigenică împotriva antigenilor COL6A3. Invenţia furnizează în special molecule noi bazate pe receptori de celule T (TCR) care sunt selective şi specifice pentru antigenul COL6A3 exprimat în tumori. TCR-ul în conformitate cu invenţia şi fragmentele de legare la antigenul COL6A3 derivate din acestea sunt utile pentru diagnosticarea, tratarea şi prevenirea bolilor canceroase care exprimă COL6A3. Mai sunt furnizaţi acizi nucleici care codifică construcţiile care recunosc antigenul în conformitate cu invenţia, vectori care cuprind aceşti acizi nucleici, celule recombinante care exprimă construcţiile care recunosc antigenul şi compoziţii farmaceutice care cuprind compuşii invenţiei.
Patent TR-200000239-T2 (TR)
Title: Metal örtülü, hava geçirmez orta gerilim tesisatları için işlem destekleyici
Inventor: KOPKE VOLKER
IPC: H02B13/045
Filed: 1998-07-30
Abstract: Bulus, fazlarin adedine uygun sayida toplam ray baglantili (SSA) islem destekleyicileri (DFS) olan metal örtülü, hava geçirmez orta gerilim tesisati ile ilgilidir, burada islem destekleyiciler (DFS) tekrar sökülebilir sekilde bir destek teknesine (STB) baglidirlar. Islem destekleyicinin (DFS) dikdörtgen prizmasi seklinde bir iç seklin (SIK) uyumlandigi dikdörtgen seklinde bir destekleyici dis biçimi (SAK) vardir, destekleyici dis biçimiyle (SAK) derstekleyici iç sekli      (SIK) arasinda bir destekleyici kiskaç araligi (SKS) bulunmasi öngörülmüstür, destekleyici iç biçimi (SIK), destekleyici tasiyici teknesine (STB) degdigi yerde destekleyici tasiyici tenekesinin (STB) bir oyugu boyunca uzanan ve serbest tarafa dogru destekleyici dis biçiminin (SAK) öbür tarafina dogru (LFL) trapez seklinde incelen bir destekleyici kilavuz seklinde (SFK) sahiptir, Islem destekleyiciler orta gerilim salter tesisatlariyla baglantili olarak enerji temini ve dagitiminda kullanilmaktadir.
Patent TR-200001105-T2 (TR)
Title: Değiştirilmiş K vitamini bağımlı polipeptidler.
Inventor: NELSESTUEN GARY L
IPC: C12N15/57
Filed: 1998-10-20
Abstract: Bulus, artmis membrana baglanma affinitesi olan K vitaminine bagimli polipeptitleri temin eder. Bu polipeptitler, memelilerde pihti olusumunu modüle etmek için kullanilabilir. Memeliletde pihti olusumunun modüle edilmesi için yöntemler de tarif edilmistir.
Patent TR-200002680-T2 (TR)
Title: Yandan girişli kablo kılavuzu
Inventor: WAMBEKE ALAIN
IPC: G02B6/44
Filed: 1999-03-03
Abstract: Bir kablo kilavuzu, boydan boya uzanan bir kanali tanimlayan koruyucu bir çepere sahiptir; çeperle örtülmüs durumdaki kablolar, kablo kilavuzu boyunca uzunlamasina geçerken bunun tarafindan tasinir ve yönlendirilir; buradaki kablo kilavuzu, koruyucu çeperde kablolarin, kablo kilavuzuna göre yanal olarak disari geçebilmesi için bir geçide sahiptir.
Patent TR-200003220-T2 (TR)
Title: İyi huylu prostat hiperplasianın tedavisinde yararlı olan yeni sübstitüe edilmiş piridino arilpiperazinler
Inventor: KUO GEE-HONG
IPC: A61P43/00
Filed: 1999-02-19
Abstract: Bu bulus Formül I'nin heterosiklik sübstitüe edilmis piperazin türevlerinin bir serisi, tedavi yöntemleri, bunlari içeren farmasötik bilesimler ve bunlarin yapiminda kullanilan ara-bilesiklerle ilgilidir. Bulusun bilesikleri seçici olarak iyi huylu prostat hiperplasiada mevcut olan bir reseptör olan alfa1a adrenerjik reseptörüne baglanmayi inhibe eder. Dolayisiyla bilesikler bu hastaligin tedavisinde potansiyel olarak yararlidir.
Patent TR-200003634-T2 (TR)
Title: Benzo(b)tiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar
Inventor: FRICK WENDELIN
IPC: C07K5/068
Filed: 1999-05-28
Abstract: Mevcut bulus ikame edilmis benzo(b)tiyepin-1,1-dioksid türevleri ve bunlarin asit ilave tuzlari ile ilgilidir. Formül I'e göre olan bilesikler, ki bu formülde R1,R2,R3,R4,R5, ve Z belirtilen anlamlara sahiptir, ve bunlarin fizyolojik tahammül edilebilir tuzlari ve fizyolojik islevsel türevleri ve bunlarin üretim usulü tarif edilmektedir. Sözkonusu bilesikler örnek olarak hipolipidemik olarak kullanilmaya uygundurlar.
Patent DE-602004007935-T2 (DE)
Inventor: GAETANI ANGELO
IPC: B62D7/02
Filed: 2004-08-02
Granted: 2008-04-17
Abstract: A steering apparatus for steering wheels (1) of a vehicle (2) comprises support means (4) arranged for supporting said wheels (1), driving means (27) arranged for rotating said support means (4) around respective longitudinal axis means (Z) and connecting means arranged for connecting said driving means (27) with said support means (4), said connecting means comprising transmission gear means (26); a vehicle comprises steered wheel means (1) and steering means (3) arranged for controlling said steered wheel means (1), said steering means (3) comprising support means (4) arranged for supporting said steered wheel means (1), driving means (27) arranged for rotating said support means (4) around respective longitudinal axis means (Z) and connecting means arranged for connecting said driving means (27) with said support means (4) , said connecting means comprising transmission gear means (26).
Patent DE-602004009909-T2 (DE)
Inventor: SAVVIDOU MAKRINA
IPC: G01N33/68
Filed: 2004-04-19
Granted: 2008-08-28
Abstract: It has been demonstrated that the level of asymmetric dimethylarginine (ADMA) increases in women that subsequently develop pre-eclampsia or whose fetus subsequently develops intrauterine growth restriction (IUGR) and that ADMA plays a key role in the development of maternal hypertension. Accordingly, the level of ADMA in a pregnant woman can be used to determine whether or not a pregnant woman is at risk of developing pre-eclampsia or whether or not a fetus is at risk of developing IUGR. Furthermore, antagonists of ADMA activity are useful in the inhibition or prevention of pre-eclampsia or inhibition or prevention of IUGR.